Drugs / H7HLAII
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06046092 | Jul 2023 → Dec 2024 | influenza | Oslo University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H7HLAII | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06046092 ↗ |
| Modality | Vaccine | “H7HLAII is a DNA vaccine” NCT06046092 ↗ |